日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/02/01 | 日証協 | 114,947株 | -10.86% | 174,275株 | -46.24% | 177,308株 | +21.19% | 42,275株 | -68.04% |
2013/01/25 | 日証協 | 128,947株 | +1% | 324,175株 | +194.7% | 146,308株 | +64.33% | 132,275株 | +43.78% |
2013/01/18 | 日証協 | 127,672株 | -0.78% | 110,000株 | -60.71% | 89,033株 | +20.26% | 92,000株 | +9100% |
2013/01/11 | 日証協 | 128,672株 | +18.4% | 280,000株 | +2053.85% | 74,033株 | -2.63% | 1,000株 | 0% |
2013/01/04 | 日証協 | 108,672株 | +4.82% | 13,000株 | -88.5% | 76,033株 | 0% | 0株 | -100% |
2012/12/28 | 日証協 | 103,672株 | +6.14% | 113,000株 | -33.92% | 76,033株 | -3.8% | 1,000株 | -98.21% |
2012/12/21 | 日証協 | 97,672株 | -19.06% | 171,000株 | +159.09% | 79,034株 | -58.85% | 56,000株 | -65.64% |
2012/12/14 | 日証協 | 120,672株 | +5.72% | 66,000株 | +842.86% | 192,084株 | +19.64% | 163,000株 | +94.05% |
2012/12/07 | 日証協 | 114,144株 | +1.78% | 7,000株 | -89.86% | 160,556株 | +18.44% | 84,001株 | +170.97% |
2012/11/30 | 日証協 | 112,144株 | 0% | 69,000株 | +76.92% | 135,555株 | -20.98% | 31,000株 | +29.17% |
2012/11/22 | 日証協 | 112,144株 | +2.75% | 39,000株 | -12.95% | 171,555株 | +2.73% | 24,000株 | -43.7% |
2012/11/16 | 日証協 | 109,144株 | -9.08% | 44,800株 | +198.67% | 166,997株 | -15.23% | 42,626株 | -20.72% |
2012/11/09 | 日証協 | 120,044株 | +7.16% | 15,000株 | -78.84% | 196,997株 | -1.49% | 53,768株 | -26.79% |
2012/11/02 | 日証協 | 112,019株 | -30.05% | 70,875株 | +293.75% | 199,972株 | -31.88% | 73,442株 | -54.67% |
2012/10/26 | 日証協 | 160,144株 | -3.61% | 18,000株 | -84.75% | 293,555株 | -1.01% | 162,000株 | -56.33% |
2012/10/19 | 日証協 | 166,144株 | -9.77% | 118,000株 | +490% | 296,555株 | +0.68% | 371,000株 | +82.76% |
2012/10/12 | 日証協 | 184,144株 | +10.17% | 20,000株 | +300% | 294,555株 | -0.34% | 203,000株 | -28.77% |
2012/10/05 | 日証協 | 167,144株 | -3.48% | 5,000株 | -97.56% | 295,555株 | +10.46% | 285,000株 | +13.09% |
2012/09/28 | 日証協 | 173,169株 | +55.81% | 205,025株 | +153.12% | 267,579株 | +26.48% | 252,001株 | +60.51% |
※株式分割は考慮していませんのでご注意ください。
Page Top